Group 1 - The core point of the article is that Huqing Zhimai (Shenzhen) Biotechnology Co., Ltd. has recently completed a Series A financing round, raising tens of millions of RMB, with a focus on 3D bioprinting technology [1] - The company was established in 2021 and is located in Shenzhen, primarily engaged in research and experimental development [1] - The registered capital of Huqing Zhimai is 8.3788063 million RMB, and it has completed its Series A financing by 2026 [1] Group 2 - Huqing Zhimai has made investments in 2 other companies and holds 121 trademark registrations and 33 patents [1] - The company has 17 administrative licenses [1] - The shareholders of Huqing Zhimai include Shenzhen Zhongguangheming Technology Partnership, Liu Boxun, Shenzhen Tongguangdaming Technology Partnership, Li Gen, and Baiyingyue (Hainan) Investment Co., Ltd. [1]
华清智美（深圳）生物科技有限公司获“A轮”融资，金额数千万人民币
Sou Hu Cai Jing·2026-01-14 01:47